TD Capital Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $90.7K | Buy |
651
+1
| +0.2% | +$140 | 0.01% | 187 |
|
|
2025
Q4 | $79.8K | Buy |
650
+1
| +0.2% | +$122 | 0.01% | 192 |
|
|
2025
Q3 | $72.1K | Buy |
649
+1
| +0.2% | +$114 | 0.01% | 189 |
|
|
2025
Q2 | $71.9K | Buy |
648
+288
| +80% | +$30.6K | 0.01% | 191 |
|
|
2025
Q1 | $40.4K | Hold |
360
| – | – | ﹤0.01% | 199 |
|
|
2024
Q4 | $33.3K | Hold |
360
| – | – | ﹤0.01% | 213 |
|
|
2024
Q3 | $30.2K | Hold |
360
| – | – | ﹤0.01% | 225 |
|
|
2024
Q2 | $24.7K | Hold |
360
| – | – | ﹤0.01% | 227 |
|
|
2024
Q1 | $26.4K | Hold |
360
| – | – | ﹤0.01% | 223 |
|
|
2023
Q4 | $29.2K | Hold |
360
| – | – | ﹤0.01% | 220 |
|
|
2023
Q3 | $27K | Hold |
360
| – | – | ﹤0.01% | 219 |
|
|
2023
Q2 | $27.8K | Hold |
360
| – | – | ﹤0.01% | 217 |
|
|
2023
Q1 | $29.9K | Hold |
360
| – | – | ﹤0.01% | 211 |
|
|
2022
Q4 | $30.9K | Hold |
360
| – | – | ﹤0.01% | 192 |
|
|
2022
Q3 | $22K | Buy |
+360
| New | +$22.7K | ﹤0.01% | 202 |
|
|
2022
Q1 | – | Sell |
-360
| Closed | -$26K | – | 195 |
|
|
2021
Q4 | $26K | Hold |
360
| – | – | ﹤0.01% | 203 |
|
|
2021
Q3 | $25K | Hold |
360
| – | – | ﹤0.01% | 190 |
|
|
2021
Q2 | $25K | Hold |
360
| – | – | ﹤0.01% | 186 |
|
|
2021
Q1 | $23K | Hold |
360
| – | – | ﹤0.01% | 179 |
|
|
2020
Q4 | $21K | Hold |
360
| – | – | ﹤0.01% | 169 |
|
|
2020
Q3 | $23K | Hold |
360
| – | – | ﹤0.01% | 146 |
|
|
2020
Q2 | $28K | Hold |
360
| – | – | ﹤0.01% | 131 |
|
|
2020
Q1 | $27K | Hold |
360
| – | – | 0.01% | 126 |
|
|
2019
Q4 | $23K | Hold |
360
| – | – | ﹤0.01% | 147 |
|
|
2019
Q3 | $23K | Hold |
360
| – | – | ﹤0.01% | 146 |
|
|
2019
Q2 | $24K | Hold |
360
| – | – | ﹤0.01% | 134 |
|
|
2019
Q1 | $23K | Hold |
360
| – | – | ﹤0.01% | 110 |
|
|
2018
Q4 | $23K | Hold |
360
| – | – | 0.01% | 110 |
|
|
2018
Q3 | $28K | Hold |
360
| – | – | 0.01% | 101 |
|
|
2018
Q2 | $26K | Hold |
360
| – | – | 0.01% | 95 |
|
|
2018
Q1 | $27K | Hold |
360
| – | – | 0.01% | 94 |
|
|
2017
Q4 | $26K | Hold |
360
| – | – | 0.01% | 94 |
|
|
2017
Q3 | $29K | Hold |
360
| – | – | 0.01% | 89 |
|
|
2017
Q2 | $26K | Buy |
360
+2
| +0.6% | +$133 | 0.01% | 85 |
|
|
2017
Q1 | $24K | Buy |
+358
| New | +$25.2K | 0.01% | 86 |
|
Other funds holding GILD
VCM
VPM
TD Capital Management's GILD Position: Q1 2026 in Review
TD Capital Management increased its Gilead Sciences (GILD) stake by 0.15% in Q1 2026, buying an estimated $140 and bringing the position to 651 shares worth $90.7K. The position accounts for 0.01% of the portfolio, ranked #187.
TD Capital Management first reported a position in GILD in Q1 2017 and has held it in 35 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- TD Capital Management held 651 shares of Gilead Sciences worth $90.7K as of Q1 2026.
- TD Capital Management bought 1 Gilead Sciences share in Q1 2026, an estimated $140.
- Gilead Sciences made up 0.01% of TD Capital Management's portfolio in Q1 2026, its #187 holding.
- TD Capital Management first reported a position in Gilead Sciences in Q1 2017 and has held it in 35 quarters since.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on TD Capital Management's 13F filing for Q1 2026, filed 11 May 2026.